In The News
Accordia partner, Dr. Ian Crozier, speaks out on his recovery and his experience treating Ebola patients in Sierra Leone
SAN FRANCISCO, CA - December 8, 2014 - New York Times highlights the story of another American doctor who was diagnosed with the Ebola virus in early September but now has made a full recovery. The Doctor, Ian Crozier, had been in Sierra Leone responding to the outbreak as a volunteer with the World Health Organization.
Dr. Ian Crozier has partnered with Accordia Global Health Foundation since 2008 - as an infectious disease clinician, medical education specialist, and operational research lead – in support of the organization’s efforts to permanently improve healthcare systems in Africa.
“I have never encountered a physician more dedicated than Ian is,” said Warner C. Greene, MD PhD, Executive Chair of Accordia Global Health Foundation, and Director of the Gladstone Institute of Virology and Immunology. “His life as a physician brought him to Africa where he is both providing the best and most compassionate care possible to his patients and building the clinical skills of his African colleagues. His decision to volunteer with the World Health Organization to respond to the Ebola crisis was completely in keeping with his selfless and courageous commitment to improving health in Africa. We at Accordia are indebted to his efforts, and are delighted that he has made a full recovery.”
Dr. Alex Coutinho, Executive Director of the Infectious Diseases Institute, Makerere University added “Ian has been a role model and hero to nearly all of our staff at IDI. His intellectual and empathetic approach to patient care is something we all aspire to as physicians, and his commitment to improving the quality of service provision for patients around the world is an inspiration to all who know him.”
To share his story and to emphasize the need for continued investment in health system reform, Accordia is pleased that Dr. Crozier will be joining us at a number of events in San Francisco this week.
Please view the article published today in the New York Times for more details.
